Prostate Cancer Foundation
.svg) |
|
| Non-Profit | |
| Founded | 1993 in Santa Monica, CA |
| Founder | Michael Milken |
| Headquarters | 1250 Fourth Street Santa Monica, CA 90401 |
|
Key people
|
Michael Milken (Chairman) Dr. Jonathan Simons (President and CEO) Dr. Howard R. Soule (Chief Science Officer) |
| Website | pcf.org |
The Prostate Cancer Foundation (PCF), headquartered in Santa Monica, CA, funds research into the prevention and cure of prostate cancer.
One in 8 U.S. men will be diagnosed with prostate cancer in his lifetime. African-American men are 70% more likely to get prostate cancer, and 2.4 times more likely for their prostate cancer to be fatal. Active duty military personnel are twice as likely to develop prostate cancer as their civilian counterparts. Several important prostate cancer discoveries made in the past two decades have been as a result of PCF’s actions, whether in funding or in coordination.
These results include the development of new medications, gene therapy approaches and the development of vaccines that signal the body’s immune system to kill cancer cells.
In 2015, 82% of the money raised by PCF went directly into research programs. Since 2007, more than $42.3 million has been awarded to the Young Investigator Program, a PCF program that gives recent MDs and PhDs the opportunity to conduct pivotal research at a critical point in their careers as research scientists.
In 2015, the PCF Global Research Enterprise supported teamwork and team science with a portfolio that included 305 active research awards totaling $118 million. There are 61 active Challenge Award teams and 110 active Young Investigators, who represent the next generation of scientific discovery. PCF’s efforts and advocacy have helped produce a 20-fold increase in government funding for prostate cancer research. This is how the prostate cancer product pipeline has turned from bone dry to a robust flow.
PCF set itself apart at its founding in 1993, when prostate cancer research was considered a dead end. PCF attempted—and has succeeded with—a new model: invest in the most innovative and promising programs that merit major investment; reduce the red tape and shorten the time from grant request to response, so that the best, most vibrant young minds get answers sooner and get to work faster; form a community with researchers, investors and pharmaceutical companies so everyone can work toward the same goals. This new model has turned prostate cancer research into one of the most vibrant and impactful fields of medical research. PCF’s global influence now extends to 19 countries.
Most recently, PCF expressed support for the goals of Vice President Joe Biden's Cancer Moonshot.
Dr. Jonathan Simons, a physician-scientist, medical oncologist, and leader in prostate cancer research is currently President, Chief Executive Officer, and David H. Koch Chair of the Foundation.
...
Wikipedia